Main Session
Sep 29
PQA 06 - Radiation and Cancer Biology, Health Care Access and Engagement

3126 - Rutherrin<sup>®</sup> Activated by Radiation Therapy Induces Synergistic Tumor Regression through Direct Destruction and Immune Activation in Multiple Preclinical Cancer Models

05:00pm - 06:00pm PT
Hall F

Presenter(s)

Mark Roufaiel, - Theralase Technologies Inc., Toronto, ON